0001437749-18-013621.txt : 20180723
0001437749-18-013621.hdr.sgml : 20180723
20180723190241
ACCESSION NUMBER: 0001437749-18-013621
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180719
FILED AS OF DATE: 20180723
DATE AS OF CHANGE: 20180723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roshan Hanif A
CENTRAL INDEX KEY: 0001664441
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20190
FILM NUMBER: 18965369
MAIL ADDRESS:
STREET 1: C/O AEON CLINICAL LABORATORIEXS
STREET 2: 2225 CENTENNIAL DRIVE
CITY: GAINESVILLE
STATE: FL
ZIP: 30504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeon Global Health Corp.
CENTRAL INDEX KEY: 0000885074
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 141673067
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 2225 CENTENNIAL DRIVE
CITY: GAINESVILLE
STATE: 2Q
ZIP: 30504
BUSINESS PHONE: 888-661-0225
MAIL ADDRESS:
STREET 1: 2225 CENTENNIAL DRIVE
CITY: GAINESVILLE
STATE: 2Q
ZIP: 30504
FORMER COMPANY:
FORMER CONFORMED NAME: AUTHENTIDATE HOLDING CORP
DATE OF NAME CHANGE: 20010327
FORMER COMPANY:
FORMER CONFORMED NAME: BITWISE DESIGNS INC
DATE OF NAME CHANGE: 19930328
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-07-19
0000885074
Aeon Global Health Corp.
AGHC
0001664441
Roshan Hanif A
AEON GLOBAL HEALTH CORP.
2225 CENTENNIAL DR.
GAINESVILLE
GA
30504
1
1
1
Chairman and CEO
Convertible Note
1.20
2018-07-19
4
D
0
255417
0
D
2017-03-20
2019-03-20
Common Stock
212847
0
D
Convertible Note
1.20
2018-07-19
4
D
0
504452
0
D
2018-03-27
2019-03-20
Common Stock
420376
0
D
Restricted Stock Rights
2018-07-19
4
A
0
911500
0
A
Common Stock
911500
911500
D
Effective on July 19, 2018 the registrant entered into a transaction with the reporting person to exchange (i) a preexisting note originally issued to the reporting person on March 20, 2017 and amended on March 27, 2018 in the aggregate principal amount of $255,417 and (ii) a preexisting note originally issued to the reporting person on March 27, 2018 in the aggregate principal amount of $504,452 for a new secured note for a maximum principal amount of $1,100,000 (the "New Note"). The New Note is not convertible into any equity securities of the registrant. The preexisting notes held by the reporting person were deemed cancelled upon the issuance of the New Note pursuant to such exchange transaction.
Represents the right to receive 911,500 shares of common stock on February 28, 2019 pursuant to the terms of a Settlement and Restructuring Agreement dated July 19, 2018 (the "Settlement Agreement") among the reporting person, the registrant and certain other parties named therein. The shares issuable under the Settlement Agreement will be deemed earned and issued on February 28, 2019.
/s/ Hanif A. Roshan
2018-07-23